🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will assess the safety, tolerability, PK, and PD of a once weekl...
Status
Completed
Location
Multiple Locations
Start Date
2004-11
Trial ID
NCT00770159
Treatments Being Tested
The aim of the MAPEG 2 study is to explore gustatory function and to follow...
Status
Recruiting
Location
Chu Dijon Bourgogne
Start Date
2023-06-12
Trial ID
NCT05888961
Nelfinavir will increase the efficacy of Cisplatin based chemo- radiation t...
Status
Completed
Location
University of Miami
Start Date
2012-01
Trial ID
NCT01485731
SRT2104 is a potent small molecule activator of SIRT1 that has been found t...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-12-09
Trial ID
NCT01014117
MyHeart Counts is a smartphone-based mobile cardiovascular health research ...
Status
Withdrawn
Location
Stanford University
Start Date
2023-01-01
Trial ID
NCT04183010
Treatments Being Tested
The overall goal of this study is to inform the design and establish feasib...
Status
Not Yet Recruiting
Location
Botswana Harvard Health Partnership
Start Date
2026-06-01
Trial ID
NCT07576842
In literature, it has been reported that exercise capacity decreases in sin...
Status
Completed
Location
Hacettepe University
Start Date
2021-09-20
Trial ID
NCT05063903
To study the effect of relocation from 2840m (Quito) to sea level (Pedernal...
Status
Unknown
Location
University Hospital Zurich
Start Date
2023-07-05
Trial ID
NCT05996302
Treatments Being Tested
This is a single-center, open-label, phase I study designed to determine th...
Status
Terminated
Location
Froedtert & the Medical College of Wisconsin
Start Date
2022-10-31
Trial ID
NCT05325281
Standard placebo-controlled, double-blind study design (TEV-50717 \[low dos...
Status
Completed
Location
Teva Investigational Site 060-0160
Start Date
2018-05-31
Trial ID
NCT03571256